Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2019-01-10 2018-12-07
Drug Identification Number 02359456 02359456
Brand name DAXAS DAXAS
Common or Proper name roflumilast roflumilast
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients Roflumilast Roflumilast
Strength(s) 500MCG 500MCG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code R03DX R03DX
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-27 2018-11-27
Estimated end date 2019-01-10 2019-01-03
Actual end date 2019-01-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments